UK-based Abcam Plc has gained exclusive rights to a portfolio of laboratory tools from Roche giving it a new source of recombinant antibodies for use by its customers in research. The financial terms of the agreement were not disclosed. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals